Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea

BACKGROUND/AIMS: This nationwide, multicenter prospective randomized controlled trial aimed to compare the efficacy and safety of 10-day concomitant therapy (CT) and 10-day sequential therapy (ST) with 7-day clarithromycin-containing triple therapy (TT) as first-line treatment for Helicobacter pylor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Beom Jin, Lee, Hyuk, Lee, Yong Chan, Jeon, Seong Woo, Kim, Gwang Ha, Kim, Hyun-Soo, Sung, Jae Kyu, Lee, Dong Ho, Kim, Heung Up, Park, Moo In, Choi, Il Ju, Yoon, Soon Man, Kim, Sang Wook, Baik, Gwang Ho, Lee, Ju Yup, Kim, Jin Il, Kim, Sang Gyun, Kim, Jayoun, Lee, Joongyup, Kim, Jae Gyu, Kim, Jae J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743805/
https://www.ncbi.nlm.nih.gov/pubmed/31505907
http://dx.doi.org/10.5009/gnl19136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743805/
https://www.ncbi.nlm.nih.gov/pubmed/31505907
http://dx.doi.org/10.5009/gnl19136

Ejemplares similares